PR Newswire BiotechOriginal article
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system
Trial Startnext-generation mapping and pulsed field ablation systemPositive
AI Analysis
Summary
The Texas Cardiac Arrhythmia Institute at St. David's Medical Center became the first U.S. facility to participate in a clinical trial evaluating a next-generation mapping and pulsed field ablation system for cardiac arrhythmia treatment.
Clinical Trial Data
Importance:3/10
Sentiment:
0.30
clinical trialcardiac arrhythmiapulsed field ablationmapping systemfirst-in-nation
Read the original article
Published by PR Newswire Biotech on September 2, 2026 1:37 PM
